Asclepes Research Centers

Weeki Wachee, Florida 34613

1 studies enrolling now · 11 studies all time

What they study most

Blood Cancer, Cardiovascular Disease, Diabetes Mellitus, Type 1, Diffuse Large B Cell Lymphoma, Epstein-Barr Virus-Associated Lymphoma, Follicular Lymphoma, Hematological Malignancy, Leukemia, Lymphocytic, Chronic, B-Cell, Locally Advanced Pancreatic Cancer, Lymphoid Malignancies, Lymphoma, Lymphoproliferative Disorders

Studies at this site

• The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies — Recruiting now
• Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC — Recruiting now
• A Phase 3 Study to Assess Efficacy and Safety of Tafasitamab Plus Lenalidomide and Rituximab Compared to Placebo Plus Lenalidomide and Rituximab in Patients With Relapsed/Refractory (R/R) Follicular Lymphoma or Marginal Zone Lymphoma. — Running, not enrolling
• A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) — Stopped early
• A Phase 2 Safety and Efficacy Study of INCB050465 in Subjects With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (CITADEL-202) — Completed
• A Study of INCB050465 in Subjects With Relapsed or Refractory Marginal Zone Lymphoma (CITADEL-204) — Completed
• Dose Escalation & Expansion Study of Oral VRx-3996 & Valganciclovir in Subjects With EBV+ Lymphoid Malignancies — Completed
• Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL — Stopped early
• Mylan Insulin Aspart Study — Completed
• A Study to Examine the Safety and Efficacy of a New Drug in Patients With Symptoms of Overactive Bladder (OAB) — Completed
• Cardiovascular Inflammation Reduction Trial — Completed